Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Landrum

Showing results (661-670 of 705) with videos related to

Pageof 71
Sort By:
JAMA Oncology|December 16, 2017
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical TrialDebra L Richardson, Michael W Sill, Robert L Coleman, et al.
Genome Medicine|November 6, 2016
Somatic cancer variant curation and harmonization through consensus minimum variant level dataDeborah I Ritter, Sameek Roychowdhury, Angshumoy Roy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|January 17, 2017
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group studyVivian E von Gruenigen, Helen Q Huang, Jan H Beumer, et al.
Nucleic Acids Research|November 29, 2019
ClinVar: improvements to accessing dataMelissa J Landrum, Shanmuga Chitipiralla, Garth R Brown, et al.
Nucleic Acids Research|November 7, 2023
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periodsBarbara Zdrazil, Eloy Felix, Fiona Hunter, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
Nucleic Acids Research|November 23, 2017
ClinVar: improving access to variant interpretations and supporting evidenceMelissa J Landrum, Jennifer M Lee, Mark Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Pageof 71

Showing results (661-670 of 705) with videos related to

Sort By:
Pageof 71
JAMA Oncology|December 16, 2017
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical TrialDebra L Richardson, Michael W Sill, Robert L Coleman, et al.
Genome Medicine|November 6, 2016
Somatic cancer variant curation and harmonization through consensus minimum variant level dataDeborah I Ritter, Sameek Roychowdhury, Angshumoy Roy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|January 17, 2017
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group studyVivian E von Gruenigen, Helen Q Huang, Jan H Beumer, et al.
Nucleic Acids Research|November 29, 2019
ClinVar: improvements to accessing dataMelissa J Landrum, Shanmuga Chitipiralla, Garth R Brown, et al.
Nucleic Acids Research|November 7, 2023
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periodsBarbara Zdrazil, Eloy Felix, Fiona Hunter, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.
Nucleic Acids Research|November 23, 2017
ClinVar: improving access to variant interpretations and supporting evidenceMelissa J Landrum, Jennifer M Lee, Mark Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Pageof 71